A blood test for HELLP syndrome
Part of Women’s health & pregnancy clinical trials.
This study compares a blood test (sCD163) in women with HELLP syndrome (a serious pregnancy complication) versus healthy pregnant women. It aims to see if this marker can help diagnose or understand HELLP better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 20 and 42 weeks.
- You have been diagnosed with HELLP syndrome (specific lab results: high LDH, high liver enzymes, low platelets).
- You do not have other chronic illnesses like lupus, kidney disease, or active infections.
- Your baby has no major birth defects or pregnancy loss at the time of diagnosis.
- For the control group: you are a healthy pregnant woman with normal blood pressure and no protein in urine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests for inflammation and platelet cells in women with HELLP syndrome after a C-section. It aims to help doctors better understand this condition and predict outcomes.
This study looks at blood-flow and artery health signs during pregnancy to better understand why preeclampsia happens. It compares women with preeclampsia to women with an uncomplicated pregnancy, and may help improve early detection and care.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This study tests a new method to measure how much fetal blood leaks into the mother's bloodstream, which can cause severe jaundice in newborns. It may help doctors diagnose hemolytic disease of the newborn earlier and more accurately.
This study looks at a specific chemical pathway that may play a role in preeclampsia, a serious pregnancy condition. It compares women with preeclampsia to healthy pregnant women to understand how the body works differently.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
Hear when a new HELLP Syndrome Complicating Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.